-
1
-
-
84878882156
-
Consumption of sweet beverages and type 2 diabetes incidence in European adults: results from EPIC-InterAct
-
[1] The InterAct consortium, Consumption of sweet beverages and type 2 diabetes incidence in European adults: results from EPIC-InterAct. Diabetologia 56 (2013), 1520–1530, 10.1007/s00125-013-2899-8.
-
(2013)
Diabetologia
, vol.56
, pp. 1520-1530
-
-
The InterAct consortium1
-
2
-
-
77949809397
-
Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk
-
[2] Malik, V.S., Popkin, B.M., Bray, G.A., Després, J.-P., Hu, F.B., Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Circulation 121 (2010), 1356–1364, 10.1161/CIRCULATIONAHA.109.876185.
-
(2010)
Circulation
, vol.121
, pp. 1356-1364
-
-
Malik, V.S.1
Popkin, B.M.2
Bray, G.A.3
Després, J.-P.4
Hu, F.B.5
-
3
-
-
66449093225
-
Consuming fructose-sweetened, not glucose- sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight / obese humans
-
[3] Stanhope, K.L., Schwarz, J.M., Keim, N.L., Griffen, S.C., Bremer, A.A., Graham, J.L., et al. Consuming fructose-sweetened, not glucose- sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight / obese humans. J Clin Invest 119 (2009), 1322–1334, 10.1172/JCI37385DS1.
-
(2009)
J Clin Invest
, vol.119
, pp. 1322-1334
-
-
Stanhope, K.L.1
Schwarz, J.M.2
Keim, N.L.3
Griffen, S.C.4
Bremer, A.A.5
Graham, J.L.6
-
4
-
-
84867221377
-
A randomized trial of sugar-sweetened beverages and adolescent body weight
-
[4] Ebbeling, C.B., Feldman, H.A., Chomitz, V.R., Antonelli, T.A., Gortmaker, S.L., Osganian, S.K., et al. A randomized trial of sugar-sweetened beverages and adolescent body weight. N Engl J Med 367 (2012), 1407–1416, 10.1056/NEJMoa1203388.
-
(2012)
N Engl J Med
, vol.367
, pp. 1407-1416
-
-
Ebbeling, C.B.1
Feldman, H.A.2
Chomitz, V.R.3
Antonelli, T.A.4
Gortmaker, S.L.5
Osganian, S.K.6
-
5
-
-
33845482041
-
A 4-wk high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in healthy humans
-
[5] Lê, K.A., Faeh, D., Stettler, R., Ith, M., Kreis, R., Vermathen, P., et al. A 4-wk high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in healthy humans. Am J Clin Nutr 84 (2006), 1374–1379.
-
(2006)
Am J Clin Nutr
, vol.84
, pp. 1374-1379
-
-
Lê, K.A.1
Faeh, D.2
Stettler, R.3
Ith, M.4
Kreis, R.5
Vermathen, P.6
-
6
-
-
33947384599
-
Impairment of hepatic Stat-3 activation and reduction of PPARalpha activity in fructose-fed rats
-
[6] Roglans, N., Vilà, L., Farré, M., Alegret, M., Sánchez, R.M., Vázquez-Carrera, M., et al. Impairment of hepatic Stat-3 activation and reduction of PPARalpha activity in fructose-fed rats. Hepatology 45 (2007), 778–788, 10.1002/hep.21499.
-
(2007)
Hepatology
, vol.45
, pp. 778-788
-
-
Roglans, N.1
Vilà, L.2
Farré, M.3
Alegret, M.4
Sánchez, R.M.5
Vázquez-Carrera, M.6
-
7
-
-
84896824742
-
Liquid fructose downregulates Sirt1 expression and activity and impairs the oxidation of fatty acids in rat and human liver cells
-
[7] Rebollo, A., Roglans, N., Baena, M., Sánchez, R.M., Merlos, M., Liquid fructose downregulates Sirt1 expression and activity and impairs the oxidation of fatty acids in rat and human liver cells. Biochim Biophys Acta 2014 (1841), 514–524.
-
(1841)
Biochim Biophys Acta
, vol.2014
, pp. 514-524
-
-
Rebollo, A.1
Roglans, N.2
Baena, M.3
Sánchez, R.M.4
Merlos, M.5
-
8
-
-
70350075402
-
Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice
-
[8] Spruss, A., Kanuri, G., Wagnerberger, S., Haub, S., Bischoff, S.C., Bergheim, I., Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. Hepatology 50 (2009), 1094–1104.
-
(2009)
Hepatology
, vol.50
, pp. 1094-1104
-
-
Spruss, A.1
Kanuri, G.2
Wagnerberger, S.3
Haub, S.4
Bischoff, S.C.5
Bergheim, I.6
-
9
-
-
43049161319
-
Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin
-
[9] Bergheim, I., Weber, S., Vos, M., Krämer, S., Volynets, V., Kaserouni, S., et al. Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. J Hepatol 48 (2008), 983–992, 10.1016/j.jhep.2008.01.035.
-
(2008)
J Hepatol
, vol.48
, pp. 983-992
-
-
Bergheim, I.1
Weber, S.2
Vos, M.3
Krämer, S.4
Volynets, V.5
Kaserouni, S.6
-
10
-
-
84949192587
-
−/− mice fed a Western-type diet enhances lipid burden and atherosclerosis despite identical calorie consumption
-
−/− mice fed a Western-type diet enhances lipid burden and atherosclerosis despite identical calorie consumption. IJC Metabolic Endocrine 9 (2015), 12–21, 10.1016/j.ijcme.2015.10.002.
-
(2015)
IJC Metabolic Endocrine
, vol.9
, pp. 12-21
-
-
Hutter, N.1
Baena, M.2
Sangüesa, G.3
Dávalos, A.4
Latasa, M.J.5
Escolà-Gil, J.C.6
-
11
-
-
0029670391
-
Aging-induced up-regulation of nuclear binding activities of oxidative stress responsive NF-kB transcription factor in mouse cardiac muscle
-
[11] Helenius, M., Hänninen, M., Lehtinen, S., Salminen, A., Aging-induced up-regulation of nuclear binding activities of oxidative stress responsive NF-kB transcription factor in mouse cardiac muscle. J Mol Cell Cardiol 28 (1996), 487–498.
-
(1996)
J Mol Cell Cardiol
, vol.28
, pp. 487-498
-
-
Helenius, M.1
Hänninen, M.2
Lehtinen, S.3
Salminen, A.4
-
12
-
-
0017184389
-
A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein–dye binding
-
[12] Bradford, M., A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein–dye binding. Anal Biochem 72 (1976), 248–254.
-
(1976)
Anal Biochem
, vol.72
, pp. 248-254
-
-
Bradford, M.1
-
13
-
-
33846878069
-
PPAR{alpha} mediates the hypolipidemic action of fibrates by antagonizing FoxO1
-
[13] Qu, S., Su, D., Altomonte, J., Kamagate, A., He, J., Perdomo, G., et al. PPAR{alpha} mediates the hypolipidemic action of fibrates by antagonizing FoxO1. Am J Physiol Endocrinol Metab 292 (2007), E421–E434, 10.1152/ajpendo.00157.2006.
-
(2007)
Am J Physiol Endocrinol Metab
, vol.292
, pp. E421-E434
-
-
Qu, S.1
Su, D.2
Altomonte, J.3
Kamagate, A.4
He, J.5
Perdomo, G.6
-
14
-
-
33845261493
-
A rapid method of total lipid extraction and purification
-
[14] Bligh, E.G., Dyer, W.J., A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37 (1959), 911–917.
-
(1959)
Can J Biochem Physiol
, vol.37
, pp. 911-917
-
-
Bligh, E.G.1
Dyer, W.J.2
-
15
-
-
0019742075
-
Assay of peroxisomal beta-oxidation of fatty acids
-
[15] Lazarow, P., Assay of peroxisomal beta-oxidation of fatty acids. Methods Enzymol 72 (1981), 315–319.
-
(1981)
Methods Enzymol
, vol.72
, pp. 315-319
-
-
Lazarow, P.1
-
16
-
-
33750153292
-
Attenuation of leptin and insulin signaling by SOCS proteins
-
[16] Howard, J.K., Flier, J.S., Attenuation of leptin and insulin signaling by SOCS proteins. Trends Endocrinol Metab 17 (2006), 365–371, 10.1016/j.tem.2006.09.007.
-
(2006)
Trends Endocrinol Metab
, vol.17
, pp. 365-371
-
-
Howard, J.K.1
Flier, J.S.2
-
17
-
-
15444377041
-
Induction of leptin receptor expression in the liver by leptin and food deprivation
-
[17] Cohen, P., Yang, G., Yu, X., Soukas, A.A., Wolfish, C.S., Friedman, J.M., et al. Induction of leptin receptor expression in the liver by leptin and food deprivation. J Biol Chem 280 (2005), 10034–10039, 10.1074/jbc.M413684200.
-
(2005)
J Biol Chem
, vol.280
, pp. 10034-10039
-
-
Cohen, P.1
Yang, G.2
Yu, X.3
Soukas, A.A.4
Wolfish, C.S.5
Friedman, J.M.6
-
18
-
-
18644362774
-
Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism
-
[18] Havel, P.J., Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism. Nutr Rev 63 (2005), 133–157, 10.1111/j.1753-4887.2005.tb00132.x.
-
(2005)
Nutr Rev
, vol.63
, pp. 133-157
-
-
Havel, P.J.1
-
19
-
-
84873908527
-
Way back for fructose and liver metabolism: bench side to molecular insights
-
[19] Rebollo, A., Roglans, N., Alegret, M., Laguna, J.C., Way back for fructose and liver metabolism: bench side to molecular insights. World J Gastroenterol 18 (2012), 6552–6559, 10.3748/wjg.v18.i45.6552.
-
(2012)
World J Gastroenterol
, vol.18
, pp. 6552-6559
-
-
Rebollo, A.1
Roglans, N.2
Alegret, M.3
Laguna, J.C.4
-
20
-
-
43049170503
-
Fructose consumption as a risk factor for non-alcoholic fatty liver disease
-
[20] Ouyang, X., Cirillo, P., Sautin, Y., McCall, S., Bruchette, J.L., Diehl, A.M., et al. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol 48 (2008), 993–999, 10.1016/j.jhep.2008.02.011.
-
(2008)
J Hepatol
, vol.48
, pp. 993-999
-
-
Ouyang, X.1
Cirillo, P.2
Sautin, Y.3
McCall, S.4
Bruchette, J.L.5
Diehl, A.M.6
-
21
-
-
78751615734
-
Reduction of liver fructokinase expression and improved hepatic inflammation and metabolism in liquid fructose-fed rats after atorvastatin treatment
-
[21] Vilà, L., Rebollo, A., Ađalsteisson, G.S., Alegret, M., Merlos, M., Roglans, N., et al. Reduction of liver fructokinase expression and improved hepatic inflammation and metabolism in liquid fructose-fed rats after atorvastatin treatment. Toxicol Appl Pharmacol 251 (2011), 32–40, 10.1016/j.taap.2010.11.011.
-
(2011)
Toxicol Appl Pharmacol
, vol.251
, pp. 32-40
-
-
Vilà, L.1
Rebollo, A.2
Ađalsteisson, G.S.3
Alegret, M.4
Merlos, M.5
Roglans, N.6
-
22
-
-
57649214103
-
Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD)
-
[22] Musso, G., Gambino, R., Cassader, M., Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Prog Lipid Res 48 (2009), 1–26, 10.1016/j.plipres.2008.08.001.
-
(2009)
Prog Lipid Res
, vol.48
, pp. 1-26
-
-
Musso, G.1
Gambino, R.2
Cassader, M.3
-
23
-
-
84911933228
-
Fructose supplementation impairs rat liver autophagy through mTORC activation without inducing endoplasmic reticulum stress
-
[23] Baena, M., Sangüesa, G., Hutter, N., Sánchez, R.M., Roglans, N., Laguna, J.C., et al. Fructose supplementation impairs rat liver autophagy through mTORC activation without inducing endoplasmic reticulum stress. Biochim Biophys Acta 2015 (1851), 107–116, 10.1016/j.bbalip.2014.11.003.
-
(1851)
Biochim Biophys Acta
, vol.2015
, pp. 107-116
-
-
Baena, M.1
Sangüesa, G.2
Hutter, N.3
Sánchez, R.M.4
Roglans, N.5
Laguna, J.C.6
-
24
-
-
79960291596
-
Liver AMP/ATP ratio and fructokinase expression are related to gender differences in AMPK activity and glucose intolerance in rats ingesting liquid fructose
-
[24] Vilà, L., Roglans, N., Perna, V., Sánchez, R.M., Vázquez-Carrera, M., Alegret, M., et al. Liver AMP/ATP ratio and fructokinase expression are related to gender differences in AMPK activity and glucose intolerance in rats ingesting liquid fructose. J Nutr Biochem 22 (2011), 741–751, 10.1016/j.jnutbio.2010.06.005.
-
(2011)
J Nutr Biochem
, vol.22
, pp. 741-751
-
-
Vilà, L.1
Roglans, N.2
Perna, V.3
Sánchez, R.M.4
Vázquez-Carrera, M.5
Alegret, M.6
-
25
-
-
84892490249
-
Liquid fructose down-regulates liver insulin receptor substrate 2 and gluconeogenic enzymes by modifying nutrient sensing factors in rats
-
[25] Rebollo, A., Roglans, N., Baena, M., Padrosa, A., Sánchez, R.M., Merlos, M., et al. Liquid fructose down-regulates liver insulin receptor substrate 2 and gluconeogenic enzymes by modifying nutrient sensing factors in rats. J Nutr Biochem 25 (2014), 250–258, 10.1016/j.jnutbio.2013.10.014.
-
(2014)
J Nutr Biochem
, vol.25
, pp. 250-258
-
-
Rebollo, A.1
Roglans, N.2
Baena, M.3
Padrosa, A.4
Sánchez, R.M.5
Merlos, M.6
-
26
-
-
0033755408
-
Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia
-
[26] Kubota, N., Tobe, K., Terauchi, Y., Eto, K., Yamauchi, T., Suzuki, R., et al. Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. Diabetes 49 (2000), 1880–1889.
-
(2000)
Diabetes
, vol.49
, pp. 1880-1889
-
-
Kubota, N.1
Tobe, K.2
Terauchi, Y.3
Eto, K.4
Yamauchi, T.5
Suzuki, R.6
-
27
-
-
84872327440
-
Pathophysiology of human visceral obesity: an update
-
[27] Tchernof, A., Despres, J.-P., Pathophysiology of human visceral obesity: an update. Physiol Rev 93 (2013), 359–404, 10.1152/physrev.00033.2011.
-
(2013)
Physiol Rev
, vol.93
, pp. 359-404
-
-
Tchernof, A.1
Despres, J.-P.2
-
28
-
-
2342449315
-
Triglycerides induce leptin resistance at the blood–brain barrier
-
[28] Banks, W.A., Coon, A.B., Robinson, S.M., Moinuddin, A., Shultz, J.M., Nakaoke, R., et al. Triglycerides induce leptin resistance at the blood–brain barrier. Diabetes 53 (2004), 1253–1260, 10.2337/diabetes.53.5.1253.
-
(2004)
Diabetes
, vol.53
, pp. 1253-1260
-
-
Banks, W.A.1
Coon, A.B.2
Robinson, S.M.3
Moinuddin, A.4
Shultz, J.M.5
Nakaoke, R.6
-
29
-
-
0027364672
-
Intermediary metabolism of fructose
-
[29] Mayes, P., Intermediary metabolism of fructose. Am J Clin Nutr 58 (1993), 754S–765S.
-
(1993)
Am J Clin Nutr
, vol.58
, pp. 754S-765S
-
-
Mayes, P.1
-
30
-
-
84855696465
-
mTORC1 serves ER stress-triggered apoptosis via selective activation of the IRE1–JNK pathway
-
[30] Kato, H., Nakajima, S., Saito, Y., Takahashi, S., Katoh, R., Kitamura, M., mTORC1 serves ER stress-triggered apoptosis via selective activation of the IRE1–JNK pathway. Cell Death Differ 19 (2012), 310–320, 10.1038/cdd.2011.98.
-
(2012)
Cell Death Differ
, vol.19
, pp. 310-320
-
-
Kato, H.1
Nakajima, S.2
Saito, Y.3
Takahashi, S.4
Katoh, R.5
Kitamura, M.6
-
31
-
-
79953794116
-
The unfolded protein response transducer IRE1alpha prevents ER stress-induced hepatic steatosis
-
[emboj201152 [pii]\r]
-
[31] Zhang, K., Wang, S., Malhotra, J., Hassler, J.R., Back, S.H., Wang, G., et al. The unfolded protein response transducer IRE1alpha prevents ER stress-induced hepatic steatosis. Embo J 30 (2011), 1357–1375, 10.1038/emboj.2011.52 [emboj201152 [pii]\r].
-
(2011)
Embo J
, vol.30
, pp. 1357-1375
-
-
Zhang, K.1
Wang, S.2
Malhotra, J.3
Hassler, J.R.4
Back, S.H.5
Wang, G.6
-
32
-
-
84969763702
-
Hepatocyte-specific disruption of CD36 attenuates fatty liver and improves insulin sensitivity in HFD fed mice
-
[32] Wilson, C., Tran, J., Erion, D., Vera, N., Febbraio, M., Weiss, E., Hepatocyte-specific disruption of CD36 attenuates fatty liver and improves insulin sensitivity in HFD fed mice. Endocrinology, 2015.
-
(2015)
Endocrinology
-
-
Wilson, C.1
Tran, J.2
Erion, D.3
Vera, N.4
Febbraio, M.5
Weiss, E.6
-
33
-
-
80053083941
-
The mammalian target of rapamycin regulates cholesterol biosynthetic gene expression and exhibits a rapamycin-resistant transcriptional profile
-
[33] Wang, B.T., Ducker, G.S., Barczak, A.J., Barbeau, R., Erle, D.J., Shokat, K.M., The mammalian target of rapamycin regulates cholesterol biosynthetic gene expression and exhibits a rapamycin-resistant transcriptional profile. Proc Natl Acad Sci U S A 108 (2011), 15201–15206, 10.1073/pnas.1103746108.
-
(2011)
Proc Natl Acad Sci U S A
, vol.108
, pp. 15201-15206
-
-
Wang, B.T.1
Ducker, G.S.2
Barczak, A.J.3
Barbeau, R.4
Erle, D.J.5
Shokat, K.M.6
-
34
-
-
84899472589
-
Rapamycin-mediated CD36 translational suppression contributes to alleviation of hepatic steatosis
-
[34] Wang, C., Yan, Y., Hu, L., Zhao, L., Yang, P., Moorhead, J.F., et al. Rapamycin-mediated CD36 translational suppression contributes to alleviation of hepatic steatosis. Biochem Biophys Res Commun 447 (2014), 57–63, 10.1016/j.bbrc.2014.03.103.
-
(2014)
Biochem Biophys Res Commun
, vol.447
, pp. 57-63
-
-
Wang, C.1
Yan, Y.2
Hu, L.3
Zhao, L.4
Yang, P.5
Moorhead, J.F.6
-
35
-
-
84904678224
-
Inflammatory stress increases hepatic CD36 translational efficiency via activation of the mTOR signalling pathway
-
[35] Wang, C., Hu, L., Zhao, L., Yang, P., Moorhead, J.F., Varghese, Z., et al. Inflammatory stress increases hepatic CD36 translational efficiency via activation of the mTOR signalling pathway. PLoS One 9 (2014), 1–12, 10.1371/journal.pone.0103071.
-
(2014)
PLoS One
, vol.9
, pp. 1-12
-
-
Wang, C.1
Hu, L.2
Zhao, L.3
Yang, P.4
Moorhead, J.F.5
Varghese, Z.6
|